- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.49 No.11
Vol.49 No.11 contents
The 50th Annual Meeting of the Japanese Society of Neurology
What I have learned and accomplished through research on multiple sclerosis (MS)
Yasuto Itoyama, M.D.
CLINICA NEUROL, 49: 699－707, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
RESCUE TREATMENTS FOR MULTIPLE SCLEROSIS
Brian G. Weinshenker, M.D., FRCP (C)
CLINICA NEUROL, 49: 708－714, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Clinical and Pathological Topics of Multiple Sclerosis
Hans Lassmann, M.D.
CLINICA NEUROL, 49: 715－718, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Fine structure of neuronal and glial processes in neuropathology, a personal historical note
Asao Hirano, M.D.
CLINICA NEUROL, 49: 719－723, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
The Japanese Society of Neurology. In commemoration of the 50th anniversary of the founding
Akira Takahashi, M.D.
CLINICA NEUROL, 49: 724－730, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Independent action of The Japanese Society of Neurology is a driving force behind the development of Japanese Neurology
Shukuro Araki, M.D.
CLINICA NEUROL, 49: 731－736, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Development of Japanese Neurology in the last half century: A global perspective
Jun Kimura, M.D.
CLINICA NEUROL, 49: 737－740, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Development of neurology in Japan and its contribution to elucidate and resolve the sociomedical problems
Shigeki Kuzuhara, M.D.
CLINICA NEUROL, 49: 741－744, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
How ought to be the specialists of neurology certified by Japanese Society of Neurology
Norihiro Suzuki, M.D.
CLINICA NEUROL, 49: 745－746, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Molecular-targeted therapy for neurodegenerative diseases
Gen Sobue, M.D.
CLINICA NEUROL, 49: 747－749, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Molecular mechanism for spinocerebellar ataxias
Osamu Onodera, M.D., Ph.D.
CLINICA NEUROL, 49: 750－752, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
The studies of gene therapy for Parkinson's disease
Hideki Mochizuki, M.D.
CLINICA NEUROL, 49: 753－755, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Approach of gene medical treatment in neurological diseases with the neurologist's "Approach of support to the patients with inherited and incurable neurological diseases."
Takanori Hazama1), Jin-ichi Sawada1) and Tatsushi Toda2)
CLINICA NEUROL, 49: 756－761, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 762－764, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 765－768, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
New international classification of epilepsy and new antiepileptic drugs for medically intractable epilepsy
Sadatoshi Tsuji, M.D.
CLINICA NEUROL, 49: 769－773, 2009
Unique clinical features and pathophysiology of anti-NMDA receptor encephalitis
Takahiro Iizuka, M.D.
CLINICA NEUROL, 49: 774－778, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
The mechanism and control of neuropathic pain
Kazuhide Inoue, Ph.D.
CLINICA NEUROL, 49: 779－782, 2009
The TDP-43 proteinopathies, toward understanding of the molecular pathogenesis
Masato Hasegawa, M.D.1), Takashi Nonaka, M.D.1), Makiko Yamashita, M.D.1), Fuyuki Kametani, M.D.1), Tetsuaki Arai, M.D.2), Mari Yoshida, M.D.3), Yoshio Hashizume, M.D.3), Kuniaki Tsuchiya, M.D.4) and Haruhiko Akiyama, M.D.2)
CLINICA NEUROL, 49: 783－785, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Regulation, structure and function of brain aquaporin
Masato Yasui, M.D., Ph.D.
CLINICA NEUROL, 49: 786－788, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Recent advance in research for myasthenia gravis, in relation to various antibodies affecting synaptic structure and function
Masaharu Takamori, M.D.
CLINICA NEUROL, 49: 789－793, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Conscious awareness of cognitive processes and their dysfunction
Kyoko Suzuki, M.D.
CLINICA NEUROL, 49: 794－796, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 797－797, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Mechanism underlying thrombus formation in cerebral infarction
Kazuo Kitagawa, M.D. and Saburo Sakoda, M.D.
CLINICA NEUROL, 49: 798－800, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Intravenous rt-PA therapy for acute ischemic stroke: efficacy and limitations
Kazunori Toyoda, M.D.
CLINICA NEUROL, 49: 801－803, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Transcranial sonothrombolysis
Hiroshi Furuhata
CLINICA NEUROL, 49: 804－806, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 807－809, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 810－810, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Exploration of pathogenesis and therapy development for ALS employing sporadic disease model
Fumiaki Tanaka, M.D.1), Masahiro Waza, M.D.1), Masahiko Yamamoto, M.D.2) and Gen Sobue, M.D.1)
CLINICA NEUROL, 49: 811－813, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor
Masashi Aoki, M.D., Ph.D., Hitoshi Warita, M.D., Ph.D., Naoki Suzuki, M.D., Ph.D. and Yasuto Itoyama, M.D., Ph.D.
CLINICA NEUROL, 49: 814－817, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Future perspectives of immunotherapy against ALS
Makoto Urushitani
CLINICA NEUROL, 49: 818－820, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Gene therapy of ALS with RNA interference
Takanori Yokota, M.D.
CLINICA NEUROL, 49: 821－823, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 824－824, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Regeneration of the central nervous system using iPS cell-technologies
Hideyuki Okano, M.D.
CLINICA NEUROL, 49: 825－826, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
The preservative therapies of injured central nervous system by gene transfer
Hiroshi Kiyama, PhD
CLINICA NEUROL, 49: 827－829, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Endogenous repair mechanisms in the brain
Kazunobu Sawamoto
CLINICA NEUROL, 49: 830－833, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Future of stem cell therapy for neuronal regeneration
Jun Takahashi, M.D.
CLINICA NEUROL, 49: 834－836, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 837－837, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Pre-symptomatic detection of Alzheimer's disease and mild cognitive impairment
Hiroyuki Arai, M.D.
CLINICA NEUROL, 49: 838－840, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Early diagnostic biomarker for Alzheimer's disease in now and future
Katsuya Urakami, M.D. and Miyoko Taniguchi, Ph.D.
CLINICA NEUROL, 49: 841－844, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Alzheimer's disease treatment by inhibition/modulation of the γ-secretase activity
Taisuke Tomita, M.D.
CLINICA NEUROL, 49: 845－847, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Vaccination therapy for Alzheimer's disease
Takeshi Tabira
CLINICA NEUROL, 49: 848－850, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 851－851, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Development of therapy for distal myopathy with rimmed vacuoles
Ichizo Nishino, M.D., Ph.D., May Christine V. Malicdan, M.D. and Satoru Noguchi, Ph.D.
CLINICA NEUROL, 49: 852－855, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Exon skipping therapy for Duchenne muscular dystrophy by using antisense Morpholino
Shin'ichi Takeda, M.D., Ph.D.
CLINICA NEUROL, 49: 856－858, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders
Tatsushi Toda, M.D.
CLINICA NEUROL, 49: 859－862, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Establishment of an evaluation method for muscular dystrophy and a patient registration system for clinical trials
Mitsuru Kawai, M.D.
CLINICA NEUROL, 49: 863－866, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 867－867, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 868－869, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Delivery of medical care to the neurological intractable diseases at home
Mieko Ogino, M.D., Ph.D. MMA.
CLINICA NEUROL, 49: 870－871, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Disaster medical network for the patients with intractable disease-experiences of two large earthquakes
Takashi Nakajima, M.D., Ph.D.
CLINICA NEUROL, 49: 872－876, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
The study and development of a new automatic suction system (SS) of intratracheal sputa -We aim at the improvement of QOL of many patients with tracheostomy mechanical ventilation (TMV) and these family's member by this new autonomic SS-
Youichi Hokezu, M.D.1), Makoto Yamamoto, M.D2), Syuichi Tokunaga3), Makoto Niikura4), Keiji Nagamatsu, M.D5), Jun-ichi Kira, M.D6), Toshihide Fukunaga, M.D7), Kouji Shima, M.D8), Seiji Kikuchi, M.D8), Itaru Kimura, M.D9), Kiyohiko Kondo, M.D10), Teruhiko Mori, M.D11), Katumasa Goto, M.D11), Shigeru Takigami, M.D12), Keiichi Shioya, M.D13) and Minako Uehara, M.N14)
CLINICA NEUROL, 49: 877－880, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 881－881, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 882－884, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Pathogenesis of sporadic Parkinson's disease: Contribution of genetic and environmental risk factors
Ryosuke Takahashi, M.D., Jun Kawamata, M.D. and Hiroki Takeuchi, M.D.
CLINICA NEUROL, 49: 885－887, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Pathophysiological process underlying Parkinson's disease: Motor & Non-motor symptoms
Atsushi Takeda, M.D.1), Toru Baba, M.D.1), Akio Kikuchi, M.D.1), Naoto Sugeno, M.D.1), Takafumi Hasegawa, M.D.1), Yasuto Itoyama, M.D.1), Toshiyuki Ishioka, M.D.2), Kazumi Hirayama, M.D.2) and Etsuro Mori, M.D.2)
CLINICA NEUROL, 49: 888－889, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Cell therapy for Parkinson disease
Shin-ichi Muramatsu, M.D.
CLINICA NEUROL, 49: 890－892, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 893－893, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Clinical Overview of Neuromyelitis Optica
Brian G. Weinshenker, M.D., FRCP (C)
CLINICA NEUROL, 49: 894－895, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Pathology of neuromyelitis optica
Tatsuro Misu, M.D.
CLINICA NEUROL, 49: 896－899, 2009
Experimental Models of Neuromyelitis Optica
Hans Lassmann, M.D.
CLINICA NEUROL, 49: 900－901, 2009
Treatment of NMO
Takahiko Saida, M.D., Ph.D.
CLINICA NEUROL, 49: 902－905, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 906－906, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Molecular genetic approach to spinocerebellar ataxias
Kinya Ishikawa, Taro Ishiguro, Makoto Takahashi, Nozomu Sato, Takeshi Amino, Yusuke Niimi and Hidehiro Mizusawa
CLINICA NEUROL, 49: 907－909, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Genetic approach for understanding of the late-onset mechanisms of polyglutamine disease
Erina Kuranaga1)2), Ayako Tonoki1)2) and Masayuki Miura1)2)
CLINICA NEUROL, 49: 910－912, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases
Yoshitaka Nagai, M.D., Ph.D.
CLINICA NEUROL, 49: 913－916, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Molecular-targeted therapies for spinal and bulbar muscular atrophy
Masahisa Katsuno, M.D.1)2), Haruhiko Banno, M.D.1), Keisuke Suzuki, M.D.1), Hiroaki Adachi, M.D.1), Fumiaki Tanaka, M.D.1) and Gen Sobue, M.D.1)
CLINICA NEUROL, 49: 917－920, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 921－921, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Molecular PET imaging for in vivo detection of amyloid in the human brain
Nobuyuki Okamura
CLINICA NEUROL, 49: 922－924, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Imaging of brain microgliosis by PET
Yasuomi Ouchi, M.D.
CLINICA NEUROL, 49: 925－928, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
In-vivo imaging for pursuing molecular cascades in the pathogenesis of neurodegenerative diseases
Makoto Higuchi, M.D.
CLINICA NEUROL, 49: 929－932, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Neuroimaging studies on higher brain functions
Toshikatsu Fujii, M.D.
CLINICA NEUROL, 49: 933－934, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 935－935, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
A history for 50 years of the prion disease research
Tetsuyuki Kitamoto
CLINICA NEUROL, 49: 936－938, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Prion disease surveillance in Japan: analysis of 1,241 patients
Masahito Yamada, M.D.1)6), Ichiro Nozaki, M.D.1), Tsuyoshi Hamaguchi, M.D.1), Moeko Noguchi-Shinohara, M.D.1), Tetsuyuki Kitamoto, M.D.2)6), Yosikazu Nakamura, M.D.3)6), Takeshi Sato, M.D.4)6) and Hidehiro Mizusawa, M.D.5)6)
CLINICA NEUROL, 49: 939－942, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 943－945, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Innovation of therapeutics and prophylaxis for prion diseases
Katsumi Doh-ura, M.D.
CLINICA NEUROL, 49: 946－948, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 949－949, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
A wide spectrum of Hereditary Motor Sensory Neuropathy (HMSN)
Masanori Nakagawa, M.D.
CLINICA NEUROL, 49: 950－952, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Therapeutic strategy for familial amyloid polyneuropathy (FAP)
Shu-ichi Ikeda, M.D.
CLINICA NEUROL, 49: 953－955, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Immune-mediated neuropathies
Susumu Kusunoki
CLINICA NEUROL, 49: 956－958, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Peripheral neuropathy and blood-nerve barrier
Takashi Kanda, M.D.
CLINICA NEUROL, 49: 959－962, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 49: 963－963, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Neurology Education and the History of the Korean Neurological Association
Kwang-Woo Lee, M.D.
CLINICA NEUROL, 49: 964－965, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
Neurology Education and History of Taiwan Neurological Society
Ching-Piao Tsai, Msc, M.D.
CLINICA NEUROL, 49: 966－967, 2009
The 50th Annual Meeting of the Japanese Society of Neurology
History of neurology and education of neurology in Japan
Shigeki Kuzuhara, M.D.
CLINICA NEUROL, 49: 968－971, 2009
